Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
Preparing Your Pediatric Practice to Care for Adolescents with Opioid Use Disorders
  • Primary Care
  • Controlled Substances CE
  • 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour of which contains 1.00 pharmacology, 1.00 Controlled Substances and 0.25 Psychopharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. The American Academy of Pediatrics recommends medication assisted treatment for adolescents with opioid use disorders (MOUD) but less than 12% of affected youth ever receive treatment and even fewer receive MOUD. In an effort to get evidence-based treatment to people with OUD, in 2021 the HHS relaxed the laws that govern MOUD prescribing. Similar to collaborative care approaches to treatment of other mental health disorders, pediatric-focused NPs should be the first person their patients look to for helping them recover from OUDs. This case-based presentation will give participants an overview of screening and evidence-based treatment for youth with OUDs, followed by practical advice and resources for preparing a practice to care for this population.
Sedation & Analgesia Outside the Box: Choices and Challenges
  • Acute Care
  • Pharmacology CE
  • Controlled Substances CE
  • 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour of which 1.25 contains pharmacology content and 1.25 is related to controlled substances. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is a recorded presentation for NAPNAP's 2024 National Conference. Pain and sedation management in the pediatric population has traditionally focused on opioids and benzodiazepines, but there are many other options. We will review the benefits of using a multimodal strategy for pain and sedation management, including the use of alternative agents and administration routes, to ensure patient comfort. We will also review side effect prevention, including delirium assessment and management.